Kohila Kurunathan
Researchers shrink brain tumours with gold nanoparticles, develop ‘mini brains’ to study psychiatric disorders
U of T researchers are inching closer to realizing a life-saving brain cancer treatment by using gold nanoparticles to make radiation therapy more effective and less toxic for patients. In their battle against glioblastoma multiforme (GBM), a rare, fast-growing cancer that begins in the brain, the multidisciplinary team has discovered that the nanoparticles can keep radiation tightly focused on the tumour, shrinking its size and preventing damage elsewhere in the body.
Behind the scenes with the Black Research Network: Groundbreakers S2 Ep.2
How is the University of Toronto promoting Black research excellence and enhancing the research capacity of Black scholars across its tri-campus community?
Those are just some of the questions explored in season two, episode two of the Groundbreakers video series as host Ainka Jess goes behind the scenes with the founders of U of T’s Black Research Network.
From mapping stars to helping youth escape poverty, student researchers break new ground
Learn more about the work of student researchers supported by the DSI, the BRN and School of Cities.
Season 2 of Groundbreakers series: Diverse research communities solving the world’s grand challenges
The premiere episode offers a behind-the-scenes glimpse at how researchers are tackling climate change and renewable energy challenges from scientific, social, economic and policy perspectives.
Critical Digital Humanities International Conference
Sept 30 to Oct 1, 2022. This year’s conference foregrounds critical DH research, praxis, and community partnerships.
CDHI 2021-22 Annual Report
It's been a big year for CDHI — and the numbers are in! 2022-23 included a robust event schedule, numerous funding opportunities, a growing online community, and new staff to welcome to the team. Learn about their first year in the 2021-22 Annual Report:
U of T and Sinai Health announce new gift from Larry and Judy Tanenbaum to establish the Tanenbaum Institute for Science in Sport
Established through a generous $20-million gift from the Larry and Judy Tanenbaum Family Foundation, the Tanenbaum Institute for Science in Sport at the University of Toronto will be a global centre of excellence for high-performance sport science and sports medicine. The Tanenbaum Institute will yield new knowledge at the intersection of research and practice, translating […]
Acceleration Consortium cements partnership with global technology leader Merck KGaA, Darmstadt, Germany
The Acceleration Consortium recently welcomed a visit from one of its new industry partners: Merck KGaA, Darmstadt, Germany. The collaboration aims to advance the emerging field of accelerated discovery using self-driving labs, which combine artificial intelligence, robotics and advanced computing to rapidly design new materials and molecules. Self-driving labs can reduce the time and cost associated with bringing advanced materials to market from an average of 20 years and $100 million to as little as one year and $1 million.
School of Cities releases plan to boost mixed-use development in Toronto
Family shelters below upscale condos, student housing above a rec centre and affordable housing built on top of community spaces offering social services. These are a few local examples of mixed-use development, a kind of urban planning not often found in Toronto that blends residential, commercial and other uses. Amid pandemic-related economic pressures and skyrocketing […]
University research can inform sector-specific actions to reach ambitious net-zero goal
Industry, governments and university researchers have distinct roles to play in advancing Canada’s clean-tech economy, a forum on reaching the country’s net-zero targets heard recently. “Roadmap to 2050 Net Zero: Building Stronger University-Industry Partnerships” was a roundtable discussion hosted by the Toronto Region Board of Trade and led by David Sinton, Engineering Professor and lead […]
U of T partners with Moderna to advance research in RNA science and technology
U of T and Moderna, Inc. – known for its mRNA-based COVID-19 vaccine – plan to work together to develop new tools to prevent and treat infectious diseases. Leah Cowen, U of T’s vice-president, research and innovation, and strategic initiatives, said U of T is excited to work alongside Moderna to protect society from current and future health threats.